Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Scott & White Cancer Research Institute (SWCRI) is a specialized research division within Baylor Scott & White Health, primarily located in Temple, Texas. It serves as a hub for clinical and translational oncology research, facilitating the transition of novel therapeutic concepts from the laboratory to clinical application. The institute manages an extensive portfolio of clinical trials, including early-phase investigations of immunotherapies, targeted agents, and combination regimens. SWCRI collaborates extensively with the National Cancer Institute (NCI) and various pharmaceutical partners to offer advanced treatment options to patients in Central Texas. Its research efforts are integrated with the Baylor Scott & White Vasicek Cancer Treatment Center, ensuring a multidisciplinary approach to cancer care. The institute is recognized for its contributions to molecular oncology and its commitment to improving patient outcomes through precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scott & White Cancer Research Institute.